Precision Medicine Platforms
Part of Healthcare - Genomics & Precision Medicine
 AZN | AstraZeneca PLC | $263.1b | $164.53 | -0.9% | 1.6M |
 TMO | Thermo Fisher Scientific, Inc. | $212.2b | $631.62 | -0.2% | 859.8K |
 DHR | Danaher Corporation | $137.1b | $216.32 | +0.4% | 1.7M |
 WAT | Waters Corp | $36.8b | $422.23 | +1.9% | 382.2K |
 GH | Guardant Health, Inc. Common Stock | $21.7b | $171.85 | +0.5% | 892.1K |
 BBIO | BridgeBio Pharma, Inc. Common Stock | $15.7b | $78.64 | -0.7% | 429.7K |
 RVTY | Revvity, Inc. | $12.9b | $128.29 | +1.6% | 727.0K |
 TECH | Bio-Techne Corp. | $11.2b | $72.47 | +0.1% | 1.0M |
 NUVL | Nuvalent, Inc. Class A Common Stock | $9.8b | $123.96 | 0.0% | N/A |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $8.5b | $370.56 | -1.8% | 78.4K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $8.5b | $120.76 | -3.6% | 364.2K |
 TEM | Tempus AI, Inc. Class A Common Stock | $8.3b | $70.64 | +3.3% | 4.8M |
 LNTH | Lantheus Holdings, Inc | $6.5b | $100.89 | +0.0% | 1.0M |
 TWST | Twist Bioscience Corporation Common Stock | $6.3b | $154.26 | +2.4% | 670.2K |
 DYN | Dyne Therapeutics, Inc. Common Stock | $4.7b | $26.21 | -0.7% | 558.9K |
 CAI | Caris Life Sciences, Inc. Common Stock | $4.4b | $27.12 | +1.3% | 1.6M |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $3.6b | $26.75 | +2.1% | 647.6K |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | $3.4b | $41.67 | +0.2% | 292.2K |
 CDNA | CareDx, Inc. | $2.3b | $52.88 | +3.9% | 787.9K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $2.0b | $90.01 | +0.2% | 157.0K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $28.80 | -2.9% | 412.7K |
 ANRO | Alto Neuroscience Inc. | $1.1b | $36.09 | -1.3% | 140.9K |
 CSTL | Castle Biosciences, Inc. Common Stock | $0.9b | $34.60 | +1.3% | 96.2K |
 AURA | Aura Biosciences, Inc. Common Stock | $0.7b | $7.72 | +0.6% | 195.5K |
 NVCT | Nuvectis Pharma, Inc. Common Stock | $0.7b | $24.89 | +0.1% | 168.3K |
 CTKB | Cytek Biosciences, Inc. Common Stock | $0.5b | $4.63 | +1.8% | 283.5K |
 SOPH | SOPHiA GENETICS SA Ordinary Shares | $477.4m | $8.84 | +3.6% | 342.9K |
 PRLD | Prelude Therapeutics Incorporated | $349.6m | $6.42 | -1.7% | 276.8K |
 LAB | Standard BioTools Inc. Common Stock | $339.8m | $0.64 | -0.9% | 818.2K |
 OABI | OmniAb, Inc. Common Stock | $284.1m | $4.61 | -5.1% | 769.2K |
 FHTX | Foghorn Therapeutics Inc. Common Stock | $266.0m | $6.13 | -8.2% | 274.6K |
 AVXL | Anavex Life Sciences | $254.8m | $3.13 | -1.9% | 397.2K |
 ACIU | AC Immune SA | $222.9m | $2.79 | -1.9% | 92.4K |
 BDSX | Biodesix, Inc. Common Stock | $219.5m | $29.27 | -4.5% | 115.7K |
 QTRX | Quanterix Corporation Common Stock | $174.8m | $2.67 | 0.0% | 217.5K |
 QSI | Quantum-Si Incorporated Class A Common Stock | $162.4m | $0.81 | +3.1% | 1.1M |
 NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $128.5m | $0.93 | -1.0% | 420.7K |
 SEER | Seer, Inc. Class A Common Stock | $123.2m | $2.02 | +0.5% | 33.2K |
 XGN | Exagen Inc. Common Stock | $113.1m | $7.56 | -1.6% | 92.1K |
 SERA | Sera Prognostics, Inc. Class A Common Stock | $82.2m | $2.01 | +1.0% | 14.5K |
 CSBR | Champions Oncology, Inc. | $74.5m | $5.08 | 0.0% | 4.0K |
 IBIO | iBio, Inc. Common Stock | $69.5m | $1.42 | -0.7% | 266.9K |
 ACRV | Acrivon Therapeutics, Inc. Common Stock | $64.2m | $2.15 | +3.4% | 149.9K |
 TVGN | Tevogen Inc. Common Stock | $29.6m | $6.75 | 0.0% | 2.4K |
 CCEL | Cryo-Cell International Inc. | $27.6m | $4.32 | +1.4% | 1.9K |
 MDXH | MDxHealth SA Ordinary Shares | $23.4m | $0.75 | +4.5% | 162.6K |
 ALLR | Allarity Therapeutics, Inc. Common Stock | $19.3m | $1.43 | +6.0% | 32.9K |
 ADVB | Advanced Biomed Inc. Common Stock | $13.2m | $9.69 | +1.2% | 368.2K |
 CDIO | Cardio Diagnostics Holdings Inc. Common stock | $4.6m | $1.86 | -4.1% | 23.4K |